US BANCORP \DE\ - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 190 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$2,305
-63.2%
678
-20.4%
0.00%
Q2 2023$6,262
-72.0%
852
-60.5%
0.00%
Q1 2023$22,357
-51.2%
2,158
-44.4%
0.00%
Q4 2022$45,799
-54.7%
3,878
-19.3%
0.00%
Q3 2022$101,000
-9.8%
4,803
+33.8%
0.00%
Q2 2022$112,000
-41.4%
3,590
-22.8%
0.00%
Q1 2022$191,000
-29.5%
4,651
-25.3%
0.00%
Q4 2021$271,000
+14.3%
6,226
+31.6%
0.00%
Q3 2021$237,000
-19.1%
4,731
+1.7%
0.00%
-100.0%
Q2 2021$293,000
-61.8%
4,650
-43.7%
0.00%
-50.0%
Q1 2021$767,000
-33.6%
8,258
-35.9%
0.00%0.0%
Q4 2020$1,155,000
+25.7%
12,891
+44.9%
0.00%0.0%
Q3 2020$919,000
+119.3%
8,894
+67.6%
0.00%
+100.0%
Q2 2020$419,000
+13.2%
5,306
-17.1%
0.00%0.0%
Q1 2020$370,000
-8.6%
6,402
-14.9%
0.00%0.0%
Q4 2019$405,000
-1.0%
7,520
-3.9%
0.00%0.0%
Q3 2019$409,000
-14.1%
7,824
-20.6%
0.00%0.0%
Q2 2019$476,000
-59.4%
9,855
-57.5%
0.00%
-66.7%
Q1 2019$1,171,000
-9.9%
23,174
+5.6%
0.00%
-25.0%
Q4 2018$1,300,000
-17.9%
21,953
-8.7%
0.00%
-20.0%
Q3 2018$1,583,000
+24.0%
24,057
-5.0%
0.01%
+25.0%
Q2 2018$1,277,000
-10.4%
25,325
-6.5%
0.00%0.0%
Q1 2018$1,425,000
+7.3%
27,085
-5.2%
0.00%0.0%
Q4 2017$1,328,000
-12.5%
28,578
-23.8%
0.00%
-20.0%
Q3 2017$1,517,000
+9.9%
37,498
-7.8%
0.01%0.0%
Q2 2017$1,380,000
+15.9%
40,690
-0.7%
0.01%
+25.0%
Q1 2017$1,191,000
-0.9%
40,985
+12.0%
0.00%0.0%
Q4 2016$1,202,000
-15.4%
36,587
-18.7%
0.00%
-20.0%
Q3 2016$1,420,000
+55.0%
45,017
+38.2%
0.01%
+66.7%
Q2 2016$916,000
-15.3%
32,578
+9.5%
0.00%
-25.0%
Q1 2016$1,081,000
-18.5%
29,739
-10.3%
0.00%
-20.0%
Q4 2015$1,327,000
+50.1%
33,169
+6.9%
0.01%
+25.0%
Q3 2015$884,000
+7.9%
31,017
+24.8%
0.00%
+33.3%
Q2 2015$819,000
+21.0%
24,851
+5.5%
0.00%0.0%
Q1 2015$677,000
+18.4%
23,548
+12.1%
0.00%
+50.0%
Q4 2014$572,000
+48.6%
21,007
+16.5%
0.00%0.0%
Q3 2014$385,000
+13.2%
18,029
+18.9%
0.00%
+100.0%
Q2 2014$340,000
+13.0%
15,157
+27.1%
0.00%0.0%
Q1 2014$301,00011,9240.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders